Acro Biomedical (ACBM) Return on Capital Employed Growth (1y) (2018 - 2025)
Acro Biomedical (ACBM) Return on Capital Employed Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | - |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | 1.00 |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | - |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | -120.00 |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | -3.00 |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | - |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | 135.00 |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | -16.00 |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | - |
| 10 | Acro Biomedical | - | - | - | 3,626.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3,626.00 |
| Sep 30, 2025 | 253,827.00 |
| Jun 30, 2025 | 205,342.00 |
| Mar 31, 2025 | 88,411.00 |
| Dec 31, 2024 | -73,729.00 |
| Sep 30, 2024 | 5.97 Mn |
| Jun 30, 2024 | 174,975.00 |
| Mar 31, 2024 | 285,971.00 |
| Dec 31, 2023 | 415,721.00 |
| Sep 30, 2023 | -5.91 Mn |
| Jun 30, 2023 | -140,793.00 |
| Mar 31, 2023 | -203,767.00 |
| Dec 31, 2022 | -214,269.00 |
| Sep 30, 2022 | -243,819.00 |
| Jun 30, 2022 | -226,195.00 |
| Mar 31, 2022 | -168,699.00 |
| Sep 30, 2021 | -63,131.00 |
| Jun 30, 2021 | -11,519.00 |
| Mar 31, 2021 | -183.00 |
| Sep 30, 2020 | 3,320.00 |